MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pantothenate kinase-associated neurodegenetration(PKAN)"

  • 2019 International Congress

    A Systems Approach Model for Pantothenate Kinase-Associated Neurodegeneration (PKAN)- Assessment and Treatment

    S. Baser, C. Muniz, F. Middleton, R. Ericson, C. Bass (Pittsburgh, PA, USA)

    Objective: Propose a new systems approach model for PKAN, investigate treatment, and establish biologic and genetic markers. Background: PKAN is a recessive, rare, inborn error…
  • 2019 International Congress

    Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic

    S. Baser, C. Muniz, F. Middleton, R. Ericson, M. Santana Jimenez, C. Bass (Pittsburgh, PA, USA)

    Objective: Analysis of a large genetically homogenous PKAN population, assessing demographics, clinical features, and rating scales to characterize observed phenotypic heterogeneity. Background: PKAN is an…
  • 2019 International Congress

    Temporal Emergence of Symptoms and Functional Impairments in Patients With Pantothenate Kinase-Associated Neurodegeneration (PKAN)

    F. Greblikas, HA. Jinnah, T. Klopstock, A. Videnovic, C. Burns (San Diego, CA, USA)

    Objective: To describe the temporal emergence of PKAN symptoms and functional impairments across the spectrum of PKAN severity. Background: PKAN, an autosomal recessive, progressive neurodegenerative…
  • 2019 International Congress

    Associations of Genetic, Epigenetic and Phenotypic Measures in the Dominican Republic PKAN Cohort

    F. Middleton, A. Espinoza, D. Larocca, R. Ericson, M. Santana Jimenez, K. Wagner, P. Stoeter, C. Bass, C. Muniz, S. Baser (Pittsburgh, PA, USA)

    Objective: To explore relationships between demographic, clinical and behavioral phenotypes and underlying genetic and epigenetic features, utilizing a large cohort of PKAN patients. Background: PKAN…
  • 2019 International Congress

    Longitudinal analysis of disease progression in a large PKAN cohort in the Dominican Republic

    C. Muniz, S. Baser, R. Ericson, M. Santana Jimenez, C. Bass, F. Middleton (Santo Domingo, Dominican Republic)

    Objective: To analyze the rate of disease progression of PKAN over a 12 year period in 37 patients with genetically-confirmed PKAN in the Dominican Republic.…
  • 2019 International Congress

    Deep Brain Stimulation for atypical tremors secondary to Neuroferritinopathy: Single center experience

    S. Chandra, J. Randhawa, M. Schiess (Houston, TX, USA)

    Objective: To describe the clinical response to deep brain stimulation. Background: Neuroferritinopathy is a neurodegenerative disease in which mutations in the ferritin light polypeptide (FTL)…
  • 2019 International Congress

    Dystonic opisthotonus: A clinical clue to neurodegeneration with brain iron accumulation in young adults

    S. Mehta, V. Lal (Chandigarh, India)

    Objective: To describe the diagnostic value of dystonic opisthotonus as a clinical clue towards a diagnosis of neurodegeneration with brain iron accumulation. Background: Differential diagnosis…
  • 2019 International Congress

    Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient

    P. Termsarasab, P. Boonkongchuen, T. Pulkes, O. Trachoo, A. Boongird (Bangkok, Thailand)

    Objective: To report a patient with PKAN whose dystonia improved with bilateral pallidal (GPi) DBS. Background: The benefits of GPi DBS are well-recognized in primary…
  • 2019 International Congress

    Pantothenate kinase-associated neurodegeneration in Tunisian families

    H. Benrhouma, I. Kraoua, H. Klaa, A. Rouissi, EM. Valente, I. Benyoussef Turki (Tunis, Tunisia)

    Objective: To describe clinical features, imaging and genetic findings of 6 Tunisian families diagnosed with PKAN. Background: Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive…
  • 2018 International Congress

    Analysis of sensory tricks in 45 patients with pantothenate kinase-associated neurodegeneration

    J. Martins, A. Darling, C. Garrido, C. Espinós, B. Dueñas, T. Temudo (Porto, Portugal)

    Objective: To analyze and classify sensory tricks developed by patients with dystonia in the setting of pantothenate kinase-associated neurodegeneration (PKAN). Background: PKAN is a progressive…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley